Dr. Lasky-Su is an Associate Professor in Medicine and associate statistician at Harvard Medical School and Brigham and Women’s Hospital. Over the last 19 years, she has focused on the analysis of genetics, genomics, and metabolomics data of various complex diseases with a primary focus on asthma over the last 15 years. The accumulation of these efforts has resulted in a productive track record of over 120 original research articles. Her ongoing R01 proposals, “The Integrative Metabolomics of Asthma Severity” (PI, R01HL123915), "Mechanistic insights into asthma pathogenesis through the integration of asthma genes, risk exposures, and metabolomics" (PI, R01HL141826) and my Department of Defense grant, “Metabolomics of lead exposure and its role in respiratory disease”, have enabled her to develop a metabolomics research program at the Channing Division of Network Medicine that focuses on using metabolomics to study the etiology of chronic lung diseases. She also serves in several metabolomics leadership capacities including being the acting chairman of the Consortium of METabolomic Studies (COMETS) and a part of the board of the International Metabolomics Society.